Tatva Chintan Pharma Chem Limited (TATVA) — Strategic Asset Allocation Index
Tatva Chintan Pharma Chem Limited (TATVA) has a Strategic Asset Allocation Index of 59.7% as of September 2022. Strategic assets (PP&E of Rs2.90 Billion plus long-term investments of Rs-) total Rs2.90 Billion, measured against net assets of Rs4.86 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Tatva Chintan Pharma Chem Limited Strategic Asset Allocation Index (2018–2022)
This chart shows how Tatva Chintan Pharma Chem Limited's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2022, the index stands at 59.7%, representing strategic assets of Rs2.90 Billion against net assets of Rs4.86 Billion INR. Explore TATVA operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Tatva Chintan Pharma Chem Limited (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tatva Chintan Pharma Chem Limited from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Tatva Chintan Pharma Chem Limited.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.6% | Rs2.11 Billion | Rs2.11 Billion | Rs- | Rs4.73 Billion | ▼ -33.9 pp |
| 2021 | 78.4% | Rs1.30 Billion | Rs1.30 Billion | Rs- | Rs1.66 Billion | ▼ -20.1 pp |
| 2020 | 98.5% | Rs1.16 Billion | Rs1.16 Billion | Rs- | Rs1.18 Billion | ▲ +7.4 pp |
| 2019 | 91.1% | Rs726.11 Million | Rs726.11 Million | Rs- | Rs797.00 Million | ▼ -21.9 pp |
| 2018 | 113.0% | Rs668.54 Million | Rs668.54 Million | Rs- | Rs591.56 Million | — |